Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP14 | P50281 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2473763 | 0.83 | ALDH1A1 (0.39) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL2472882 | 0.83 | ALDH1A1 (0.56) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL2469239 | 0.78 | CYP3A4 (0.55) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL2475916 | 0.75 | CYP3A4 (0.51) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL2473962 | 0.74 | CYP3A4 (0.50) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL75662 | 0.68 | ALDH1A1 (0.45) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL384175 | 0.68 | ALDH1A1 (0.58) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL4646558 | 0.67 | ALDH1A1 (0.43) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL25428299 | 0.66 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 | |
| SCHEMBL6550806 | 0.66 | ALDH1A1 (0.42) | ALDH1A1CYP3A4TSHRTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1460056-B1 | METHOD FOR PRODUCING A CARBONIC ESTER | ASAHI KASEI CHEMICALS CORP (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-20050080274-A1 | Process for producing carbonic ester | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1460056-A1 | PROCESS FOR PRODUCING CARBONIC ESTER | Asahi Kasei Chemicals Corporation (JP) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080274-A1 | Process for producing carbonic ester | CYP2E1, ADH1A, ALKBH3 | ALDH1A1 264/4885CYP3A4 9/4885TSHR 3770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.